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We describe a case of Q fever endocarditis in an HIV-
infected patient. The case was treated successfully with
valvular replacement and a combination of doxycycline and
hydroxychloroquine. We review the current literature on Q
fever endocarditis, with an emphasis on the co-infection of
HIV and Coxiella burnetii.
C
oxiella burnetii is classified in the order Legionellales
and is closely related to Legionella and Francisella
spp. (1). This zoonotic agent has been isolated from vari-
ous birds, mammals, and arthropods and is considered
endemic in cattle in some regions of the United States
(2,3). Although usually nonpathogenic in animals, out-
breaks of C. burnetii–induced abortions have been
described in goats and sheep. In humans, C. burnetii is
acquired primarily by inhaling infectious dust (4). The
bacteria are able to survive in a sporelike form under
harsh environmental conditions and are extremely conta-
gious: a single organism can cause disease (5). Q fever
manifests as acute or chronic disease. The acute disease
may include an undifferentiated febrile syndrome, pneu-
monia, or hepatitis. The most common chronic symptom
is endocarditis (6). We describe a case of Q fever endo-
carditis in a patient with HIV infection. This co-infection
has never been reported in the United States and rarely has
been described elsewhere.
The Study
A 46-year-old man with HIV infection was admitted to
an emergency department in August 2002 with sudden
onset of chest pain and shortness of breath. The patient was
born in Mexico and recalled contact with farm animals and
consuming unpasteurized dairy products while raised in
the state of Chihuahua. He migrated to United States in
1987 and returned periodically to Mexico, most recently in
1998. While residing in the United States, the patient had
no known direct or indirect exposures to ruminants.
Ten months before admission (November 2001), the
patient had been hospitalized with pneumonia and was
diagnosed with HIV infection. One month later, the patient
was hospitalized because of Candida esophagitis and
thrombocytopenia. Abone marrow biopsy obtained during
that hospitalization showed adequate megakaryocytes,
mild megaloblastic changes in erythroid precursors, and
adequate iron stores. Special stains and cultures for acid-
fast bacilli and fungi were negative, as were blood cultures
for Mycobacterium avium complex. During that admission
a diastolic murmur was noted, and an echocardiogram
showed severe aortic insufficiency with a thickened aortic
valve. The patient was discharged on antiretroviral therapy
with lamivudine, stavudine, and nelfinavir, diuretics and
ACE inhibitors. 
Seven weeks before the first hospitalization in
November 2001, the patient was admitted with headache,
neck rigidity, and chills. Computed tomography scans of
the head and neck and a lumbar puncture showed no
abnormalities. The symptoms resolved with the use of
empiric intravenous vancomycin and ceftriaxone. Because
of persistent thrombocytopenia, a second bone marrow
biopsy was performed in February 2002. Granulomas were
identified in the biopsy, although special stains for acid-
fast bacilli and fungi were negative. Treatment with clar-
ithromycin, ethambutol, and rifabutin for presumed M.
avium complex was initiated. and the patient was dis-
charged.
On examination, pulse was 101 beats per minute, tem-
perature was 37.0°C, respiratory rate was 22 beats per
minute, and blood pressure was 113/42 mm Hg. Mild tem-
poral wasting, absence of oral thrush, poor dentition, posi-
tive jugular venous distention, bilateral crackles in the
lungs, a decrescendo diastolic murmur in the left sternal
border, “water hammer” pulses, and clubbing of the digits
were found. Serum sodium level was 129 mEq/L; creati-
nine 1.4 mg/dL; albumin 3.2 mg/dL; normal liver function
tests; leukocyte count 8,800/µL, with 90.8% neutrophils
and 7.3% lymphocytes and hemoglobin 8.2 g/dL and
platelets 72,000/µL. Antibodies to nuclei and smooth mus-
cle were detected at titers of 1:40 and 1:160, respectively.
CD4+ lymphocyte count was 82 cells/mm3 and viral load
2,838 copies/mm3. Chest x-ray showed cardiomegaly and
congestive heart failure. An electrocardiogram showed a
left anterior hemiblock and a first-degree atrioventricular
block. A transthoracic echocardiogram showed a large
vegetation on the aortic valve and severe aortic insufficien-
cy. Other findings included left ventricular dysfunction, a
structurally normal mitral valve with a small vegetation on
the atrial surface of the anterior leaflet, and mild mitral
regurgitation. Empiric treatment for bacterial endocarditis
was initiated with oxacillin, gentamicin, and ampicillin.
Because of severe aortic insufficiency, the patient’s aortic
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 3, March 2004 501
*Cook County Hospital, Rush Medical College, Chicago, Illinois,
USA; and †Centers for Disease Control and Prevention, Atlanta,
Georgia, USAvalve was surgically resected and showed a severely fen-
estrated, tri-leaflet valve with bulky, white, irregular vege-
tations. The mitral valve was free of vegetations, but was
perforated and required repair with an autologous pericar-
dial patch. Initial histopathologic evaluation of the excised
aortic valve reported scant inflammation and extensive
calcification and hyalinization. The patient did well post-
operatively and was discharged after 4 weeks of intra-
venous antimicrobial therapy. Blood cultures obtained
before antimicrobial drugs were administered failed to
grow routine aerobic or anaerobic bacteria, mycobacteria,
or fungi.
After discharge, serum samples tested by an indirect
immunofluorescence antibody (IFA) assay showed
immunoglobulin (Ig) G antibodies reactive with phase I
and II antigens of C. burnetii at reciprocal titers of 16,384
and 16,384, respectively. The resected valve was sent to
the Centers for Disease Control and Prevention.
Histopathologic evaluation showed calcification and
hyalinization and foci of prominent mononuclear infil-
trates with occasional multinucleated giant cells. An
immunohistochemical stain for C. burnetii using a poly-
clonal mouse primary antibody reactive with C. burnetii
was applied to sections of valve tissue. Abundant intracel-
lular staining of Coxiella antigens was identified in foamy
macrophages in areas of inflammation and calcification
(Figure). The patient was started on doxycycline 100 mg
per os each day and hydroxychloroquine 400 mg per os
each day. During a follow-up visit 4 months after hospital-
ization, the patient was clinically asymptomatic, platelet
count was 146/µL, albumin was 4.2 mg/dL, and no antinu-
clear antibodies were detected. Follow-up antibody titers
against phase I and II antigens of Coxiella were both
4,096. 
Conclusions
Q fever has a worldwide distribution (7) and, in the
United States, was made nationally notifiable in 2000. The
disease is not reportable in Mexico, our patient’s country
of origin, and only one case report of Q fever endocarditis
has been published from that country (8).
Pneumonia developed in our patient several months
before endocarditis was diagnosed; however, the role of C.
burnetii as the etiologic agent of his prior pulmonary dis-
ease is not known. A syndrome characterized by absence
of fever; insidious aortic valvular dysfunction, leading to
congestive heart failure; anemia; thrombocytopenia; and
autoantibodies subsequently developed in our patient.
Routine blood cultures were negative. Culture-negative
endocarditis is implicated in 6% of cases of infective endo-
carditis in HIV-infected patients. Some of the pathogens
identified as the cause of culture-negative endocarditis in
this patient cohort include Bartonella,  Coxiella, and
Arcanobacterium. However, because diagnostic assays for
Q fever are attempted infrequently, the number of culture-
negative endocarditis cases caused by C. burnetii is
unknown (9–11).
Although infections with certain intracellular organ-
isms (e.g., Mycobacterium, Salmonella, and Leishmania
spp.) are more frequent and have more severe signs and
symptoms in HIV-infected patients, the prevalence and
severity of Q fever in persons infected with HIV compared
with the general population remain controversial. Raoult et
al. (12) found a threefold increase in prevalence of Q fever
serologic findings among HIV-infected patients in
Marseille, France (2.4% vs. 0.8%), and determined an
annual incidence of 2.7 per 100,000 in the general popula-
tion and 33 per 100,000 in HIV-seropositive patients (4).
However, other seroprevalence studies failed to confirm an
increase of Q fever in HIV-seropositive patients (13–15). A
study from Italy described two outbreaks of Q fever in a
residential facility for drug abusers. In the first epidemic,
the Q fever attack rate was 45.9% for HIV-seropositive
persons compared with 25.1% for HIV-seronegative per-
sons. However, during the second outbreak 1 year later, no
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Figure. Immunohistochemical localization of Coxiella burnetii anti-
gens in the aortic valve of a patient co-infected with HIV. Intact
bacteria and fragment antigens are identified predominantly with-
in macrophages in the fibrosed and calcified valve tissue.
(Immunoalkaline phosphatase stain with naphthol phosphate fast-
red substrate and hematoxylin counterstain, original magnification
x100).significant association with HIV coinfection or CD4+ cell
count existed, and no significant differences occurred in
the levels of antibodies or the clinical signs and symptoms
between these patient cohorts in either outbreak (16).
Even less information is available about Q fever endo-
carditis in persons infected with HIV. C. burnetii is con-
trolled by a nonsterile immunity and perhaps is never
cleared from an infected patient (17). Because C. burnetii
is an intracellular pathogen, Q fever endocarditis might be
expected to occur with greater frequency in HIV-infected
patients than in the general population; however, most
cases of chronic Q fever occurring in immunosuppressed
patients have been reported among persons with cancer (6)
and only rarely among HIV-infected persons (6,12). 
Q fever endocarditis was suspected in our patient on the
basis of his clinical manifestations, history of exposure to
farm animals, and absence of bacterial growth in routine
blood cultures. Conventional blood cultures for C. burnetii
are characteristically negative, but use of shell vial cell
culture assay techniques are more sensitive and less haz-
ardous than conventional blood cultures (18). 
The diagnosis in our patient was confirmed by serolog-
ic and immunohistochemical methods. Chronic Q fever
can be diagnosed by detection of high anti-phase I IgG
antibody titers by IFA, complement fixation, or enzyme
immunoassay (19). IFA is considered the serologic stan-
dard criterion and was the test used in our patient.
Nonspecific, low-dilution seropositivity for Coxiella has
been reported in HIV-seropositive persons by IFA(12), but
our patient had very high titers compatible with Coxiella
infection. Also, some patients with C. burnetii have been
found to have false-positive results by HIV enzyme-linked
immunosorbent assay (20,21). This finding was not the
case in our patient, who had a confirmatory Western blot
for HIV and a low CD4+ cell count.
Echocardiography showed a large vegetation in our
patient. This finding is relatively unusual in patients with
Q fever endocarditis, and transthoracic echocardiogram
rarely demonstrates vegetation (6). Because of the difficul-
ty of diagnosing Q fever endocarditis with the current
Duke’s criteria, particularly when blood cultures are nega-
tive and vegetation is absent, a modification has been sug-
gested so that a single positive blood culture or a high
anti-phase I antibody titer is considered diagnostic (22).
Acombination of doxycycline and hydroxychloroquine
was given to our patient, who is currently clinically well.
Although no data specifically describe the treatment of Q
fever endocarditis in HIV-infected patients, the combina-
tion of both antimicrobial drugs appears to be an effective
therapeutic regimen for this disease. Hydroxychloroquine
increases the pH of phagolysosomes, enhancing the activ-
ity of doxycycline against C. burnetii. This combination of
drugs can reduce the duration of treatment from 3–4 years
to 18 months (23), although some authorities recommend
that treatment be continued indefinitely.
Q fever endocarditis is a potentially severe infection,
with a case-fatality ratio of approximately 24% in histori-
cal case series (6). Earlier diagnosis and newer treatment
combinations may improve survival and decrease rates of
recurrence. Further studies are required to evaluate the
long-term prognosis of Q fever endocarditis in patients
with HIV. Q fever is infrequently diagnosed in persons
with endocarditis because of its relative rarity and because
it is seldom considered in the differential diagnosis.
However, it should be considered in all patients with cul-
ture-negative endocarditis, particularly those with appro-
priate risk factors that include past or current exposure to
livestock.
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